Drug Safety Flashcards

1
Q

What is pre-clinical testing?

A

Where pharmaceutical companies trial drugs for toxicity in a number of tissue in vitro or in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does drug licensing require?

A

Requires 2 rodent species and 1 non-rodent species through intra-venous, intra-peritoneal or oral dosing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are Phase 1 trials?

A

20-100 healthy volunteers are given the drug to assess the pharmacokinetics and to determine dosing regiments and safety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Phase 2 trials?

A

100-500 patients with the disease/condition given the drug

Looks at efficacy and side-effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are Phase 3 trials?

A

1000-5000 patients given the drug

Assesses long-term use and its efficacy - better than best current treatment?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much does it cost to fully develop a drug?

A

≈1Bn pounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How long does it take to develop a drug?

A

12-15 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are adverse drug reactions?

A

It is a response to a medicinal product which is noxious and unintended

This event has at least reasonable probability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are type A adverse drug reactions?

A

Exaggeration of a drugs normal pharmacological actions when given the usual recommended dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What’s an example of a type A adverse drug response?

A

Respiratory depression with codeine in CYP2D6 ultra-rapid metabolisers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are type B adverse drug reactions?

A

Move, responses that are unexpected/unpredictable from the known pharmacological actions of the drug. May only be discovered after the drug has already been made available for general use

These are rare; 1:100,000 patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give 2 examples of type B ADRs.

A

Anaphylaxis with penicillin

Skin rashes with antibiotics

Typically immune mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are type C ADRs?

A

Persist for a relatively long time after drug withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are type D ADRs?

A

Become apparent some time after use. Timing may make them more difficult to detect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are type E ADRs?

A

Associated with the withdrawal of the medicine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are idiosynchratic ADRs?

A

Type B adverse drug reactions - off target

17
Q

What was thalidomide originally - then laterally - marketed as?

A

A sedative/hypnotic

Later marketed to alleviate morning sickness

18
Q

What did thalidomide cause?

A

Teratogen

Inflammation of fat cells under the skin

19
Q

How long is the exclusivity license after a drug is marketed for general use?

20
Q

What % of drugs have been withdrawn over safety concerns over past 20 year?

A

4% of all licensed drugs

21
Q

What effects does ADRs have on pharmaceutical companies?

A

Risk of ADRs make them more cautious and hence less inventive for new ideas

Prevent potentially good drugs from getting to the market and helping patients who could benefit

22
Q

What is cervastatin?

A

A lipid lowering drug

23
Q

Why was cervastatin removed from the market?

A

52 deaths reported from kidney failure - rhabdomyolysis - post marketing

24
Q

How many hospital admissions are because of ADR?

25
How many patients develop ADR prolonging it?
10-20%
26
How many deaths per annum in the USA due to ADRs?
100,000 deaths per annum
27
How much do ADRs cost the NHS every year?
£2.2Bn per year
28
Why can’t idiosynchratic ADRs be predicted?
Preclinical animal and cell toxicity screens are not representative of human mechanism ADRs are rare and not observed until wider use of drug - 10k-100k patients
29
How can ADRs be predicted better?
Better “humanized” animal models Pre-treatment predictive bio-markers
30
Why did 5/15 healthy volunteers die in trials for Fialuridine?
Because animal model of liver toxicity was not representative of human
31
What models are out there currently that give a better picture for detecting potential ADRs?
‘Humanized’ mouse liver 3D models Tissue culture models Tissue-organ models
32
What is abacavir? What were it’s ADRs?
A reverse transcriptase inhibitor used in HIV treatment Hypersensitivity syndrome ~9% of patients showed this after first 6 weeks Symptoms include: Fever Fatigue GI and respiratory problems
33
What is hypersensitivity caused by abacavir strongly associated with? What did this cause?
Strongly associated with genetic variant HLA-B* 57:01 Patients screened beforehand reduced incidence of hypersensitivity to 0% Screening is now mandatory before receiving abacavir PPHARMACOGENOMICS